altona Diagnostics announces leadership transition
New General Managers appointed
Advertisement
altona Diagnostics GmbH announces a leadership transition. Dr. Ulrich Spengler and Dr. Markus Hess, the current General Managers, are transferring the management responsibilities to Dr. Sönke Friedrichsen and Hans Kuhn.
New leadership for a growing company
Reflecting the development and expansion of altona Diagnostics, Dr. Ulrich Spengler and Dr. Markus Hess have decided to hand over responsibility for the IVD company altona Diagnostics to a new generation of leaders. Since July 1, 2024, Dr. Sönke Friedrichsen has been overseeing technical operations, while Hans Kuhn has taken charge of the financial and business-related functions.
Hans Kuhn brings extensive experience to his new role. He served in different leadership roles in finance and administration at altona Diagnostics from 2011 to 2017, and most recently as the General Manager of the altona Diagnostics subsidiaries in Argentina and Brazil. His understanding of the company’s financial landscape and international business experience will serve him well in his new position.
Dr. Sönke Friedrichsen has been with altona Diagnostics since 2013, serving as Head of Research & Development since 2017. His leadership in steering the product, process, and equipment innovations has been instrumental in the company’s success.
Dr. Ulrich Spengler will move to the altona Diagnostics Holding GmbH as General Manager, while Markus Hess will remain General Manager until further notice and will act in an advisory capacity until his departure.
Commitment to shared responsibilities and growth
Dr. Spengler commented on the new management structure and the general corporate culture: “This change reflects our efforts to shift decision-making to senior employees and thus encourage those who want to take on more responsibility within the company. By handing over operational management to Hans Kuhn and Sönke Friedrichsen, we are not only supporting the further development of our growing company, but also transferring important decision-making powers to younger managers.”
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Last viewed contents
Silk sponges instead of animal testing - How a 3D cell culture system could revolutionize cancer diagnostics
Next-generation sequencing: NGS-based diagnostics for identifying sepsis pathogens wins EARTO Innovation Award
Novel Technique Improves Brain-State Detection - New method boosts precision of a non-invasive brain-state classification with functional near-infrared spectroscopy (fNIRS)
Bacteria ‘pills’ could detect gut diseases — without the endoscope - “This technology provides a new paradigm for rapid and non-invasive detection of gastrointestinal diseases”
When is genome sequencing advisable? - Human geneticists conduct clinical reference study for the diagnosis of genetic diseases
GenNext Technologies and Thermo Fisher Scientific Collaborate - Simplify Structural Biology for Faster Biotherapeutic Development
What the sea spider genome reveals about their bizarre anatomy - The first high-quality pycnogonid genome provides novel insights in chelicerate evo-devo
Analytica USA: Expert knowledge for research and practice - Special show Digital Transformation: a hands-on Smart Lab
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine - Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
Researchers identify a potential biomarker for long COVID - Extracellular vesicles in study participants contain SARS-CoV-2 peptides
Dana-Farber Cancer Institute unveils groundbreaking blood test for multiple myeloma